Erratum: Multicentre phase III trial on fludarabine, cytarabine (Ara-C) and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients (British Journal of Haematology (2005) 131, (172-179))

Russo D.;Malagola M.

Writing – Original Draft Preparation

;De Vivo A.;Fiacchini M.;Martinelli G.;Piccaluga P. P.;Damiani D.;Candoni A.;Michielutti A.;Castelli M.;Testoni N.;Ottaviani E.;Rondoni M.;Pricolo G.;Mazza P.;Zuffa E.;Zaccaria A.;Raspadori D.;Bocchia M.;Lauria F.;Bonini A.;Avanzini P.;Gugliotta L.;Visani G.;Fanin R.;Baccarani M.

2006-01-01